StockData
Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc. (HIMS) company profile

HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30171% above fair value
$17.55−1.01 (-5.44%)

Close on Nov 17, 2026Market cap $4.09BP/E –Yield –

About Hims & Hers Health

Services-Offices & Clinics of Doctors of Medicine, SIC 8011

Hims & Hers Health, Inc. operates a digital consumer healthcare platform that connects patients with licensed healthcare professionals and fulfillment services. The company provides personalized access to prescription medications, compounded treatments, and over-the-counter wellness products focusing on areas such as sexual health, hair loss, dermatology, mental health, and weight management. Additionally, it offers comprehensive laboratory testing and health assessment services directly through its websites and mobile applications, serving consumers primarily on a recurring subscription model.

The company operates across the United States, Canada, the United Kingdom, and parts of the European Union, including Germany, France, Spain, and the Republic of Ireland. Fulfillment and manufacturing operations include two domestic pharmacies, two facilities licensed in the United Kingdom, an outsourcing facility, a peptide facility, and a laboratory center. The provided text details operations across these international regions without stating a specific headquarters location.

Summary of the business section of Hims & Hers Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Hims & Hers Health, Inc.
Founded
2017
Headquarters
San Francisco, CA
Address
2269 Chestnut St, #523 94123
Phone
(415) 851-0195
Employees
1,046, Dec 31, 2025
Industry
Services-Offices & Clinics of Doctors of Medicine
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, San Francisco, CA

Stock & identifiers

Ticker
HIMS
Former tickers
OACU until Mar 22, 2021; OAC until Aug 13, 2020
Exchange
NYSE
IPO date
Jul 19, 2019
Shares outstanding
233M, Aug 7, 2026
Public float
$10.10B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1773751
CUSIP
433000106
ISIN
US4330001060
FIGI
BBG00Q53VYM7
Share class FIGI
BBG00Q5LQWK9
LEI
254900V041EIVTSB6D58
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Deborah M. AutorChief Policy Officer, Director72,789
Andrew DudumChief Executive Officer, Director16,686,948
Soleil BoughtonChief Legal Officer314,648
Patrick Harrison CarrollChief Medical Officer213,574
Michael ChiChief Operating Officer487,848
Oluyemi OkupeChief Financial Officer277,559
Mohamed ElshenawyCTO278,044
Jonathan M. FranklinChief Accounting Officer–
Irene BecklundPAO20,475
Nader KabbaniChief Operating Officer–
Melissa BairdChief Operating Officer817,829
David B. WellsDirector230,859
Christopher D. PayneDirector145,673
Andrew D. HubermanDirector–
Kare SchultzDirector26,020
Kofi Owusu Amoo-GottfriedDirector–
Anja ManuelDirector38,671
Garcia Andrea G. PerezDirector83,822
Delos M. CosgroveDirector67,995
Christiane PendarvisDirector55,430

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$22.96M$159.73M$17.51M$210$113
FY2024$24.61M$110.27M$7.24M$157$98
FY2023$14.40M$21.36M$6.53M$58$76
FY2022$10.82M$10.73M$4.99M$42$47
FY2021$15.23M$26.76M$3.33M$42$90
FY2020$26.58M$74.02M$3.86M$0$0

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsIncentive payOtherTotalvs. prior year
Dudum
Chief Executive Officer and Chairman
$494.79K–$10.64M$11.00M$585.76K$243.00K$22.96M-7%
Okupe
Chief Financial Officer
$530.88K–$7.47M–$376.76K$17.48K$8.40M+2%
Elshenawy
Chief Technology Officer
$375.00K$3.00M$57.22M–$278.47K–$60.87M–
Chi
Chief Operating Officer (previously Chief Commercial Officer)
$485.00K–$6.90M–$340.91K$3.00K$7.73M+10%
Boughton
Chief Legal Officer
$464.38K–$4.02M–$305.07K$3.00K$4.80M+3%
Baird
Former Chief Operating Officer
$341.29K–$8.05M––$3.00K$8.39M-8%
Kabbani
Former Chief Operating Officer
$227.27K$1.00M$13.49M––$148.83K$14.86M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Jul 19, 2019
Offer price
$10.00
Securities offered
17,500,000
Gross proceeds
$175.00M
Exchange
NYSE
First trading day
Sep 9, 2019
First-day close
$9.88-1.2%
Lock-up ends (est.)
Mar 7, 2020

“Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“Our number of employees has also increased significantly over the last few years, from 1,046 employees as of December 31, 2023 to 2,442 employees as of December 31, 2025.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 9, 2021DelistingNotice of delisting from exchange (Form 25)
Jan 26, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 26, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 21, 2021DelistingNotice of delisting from exchange (Form 25)
Jan 19, 2021Name changeName changed from Oaktree Acquisition Corp. to Hims & Hers Health, Inc.
Oct 23, 2020MergerRegistration of securities for a merger or exchange offer (S-4)
Jul 19, 2019IPOInitial public offering priced (424B4 prospectus)
Jul 16, 2019ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?